EMCDDA Home
  • EN
Search

Figure TDI-3. Trend in estimated number of all clients entering treatment by selected primary drug used, 2006–11

Part (i) Percentage by primary drug

 
 
Primary drug200620072008200920102011
Related links:
Heroin474947464343
Cocaine161718161515
Cannabis212022242627
Other stimulants665566
Other drugs1189999
See also ‘General notes for interpreting data’ on the Explanatory notes and help page
See also Table TDI-102 and Figure TDI-1 part (ii)

Notes:

Countries included: Bulgaria, Czech Republic, Denmark, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Luxembourg, Latvia, Lithuania, Hungary, Netherlands, Austria, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, United Kingdom, Croatia and Turkey.

Data for Latvia, Lithuania and Portugal are for clients entering treatment for the first time in their life.

Missing data were interpolated by assigning for the respective country the value for most recent year available. Altogether, 2.7% of the data points and 7.4% of the number of clients were interpolated. In 2011 the percentage of not known / missing cases for primary drug were of about 9% of all the clients entering in treatment for the first time in their life. For not known / missing cases in the previous years please see Figure TDI - 3 (part ii).

Sources:

Reitox national reports 2012 & TDI

Primary drug 2006 2007 2008 2009 2010 2011
Heroin 47 49 47 46 43 43
Cocaine 16 17 18 16 15 15
Cannabis 21 20 22 24 26 27
Other stimulants 6 6 5 5 6 6
Other drugs 11 8 9 9 9 9

tdifig3a

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 08 May 2013